Rational Design and Application of Lipid‐Based Nanocarriers in Hepatic Disorders (IMAGE)

Sichuan International Medical Exchange and Promotion Association

Rational Design and Application of Lipid‐Based Nanocarriers in Hepatic Disorders

Caption

Schematic illustration showing the classification of lipid‐based nanocarriers (LBNCs) (including liposomes, micelles, nanoemulsions, SLNs/NLCs, LNPs, BLNs, SRLNCs) and their targeted delivery to different liver cells (hepatocytes, hepatic stellate cells, liver sinusoidal endothelial cells) for treating liver diseases like hepatitis, liver fibrosis, fatty liver, and hepatocellular carcinoma.

Credit

Xinxin Zhang

Usage Restrictions

Marked by the credited.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.